市場調査レポート

商品コード

1792676

血行動態モニタリング市場：市場規模・シェア・動向・予測、製品別、モニタリング手法別、エンドユーザー別、地域別（2025～2033年）

Hemodynamic Monitoring Market Size, Share, Trends and Forecast by Product, Monitoring, End-User, and Region, 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 444,331円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 592,491円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 740,651円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.16円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の血行動態モニタリングの市場規模は、2024年に11億9,688万米ドルとなりました。今後、IMARC Groupは、市場は2033年までに17億3,181万米ドルに達し、2025年から2033年にかけて3.98%のCAGRを示すと予測しています。北米が市場を独占し、2024年には35%という大きな市場シェアを占めています。高い医療支出、高度な病院インフラ、モニタリング技術の普及、熟練した専門家、強力な規制支援などが血行動態モニタリング市場シェアに寄与しています。

市場はいくつかの重要な要因によって牽引されています。心血管疾患や呼吸器疾患の罹患率上昇により、クリティカルケアにおける高度モニタリングシステムの需要が高まっています。人口の高齢化と外科手術の増加がこの需要に寄与しています。病院やICUは、患者の転帰を改善するため、リアルタイムで正確なモニタリングを優先しています。低侵襲・非侵襲技術は、合併症や回復時間の短縮につながるため、人気を集めています。センサー、データ分析、ワイヤレス接続の技術向上により、これらのシステムはより効率的で使い勝手の良いものとなっています。さらに、医療インフラに対する政府の投資や、早期診断と予防医療への関心の高まりが、血行動態モニタリング市場の成長を支えています。医療システムがより良い患者管理を推進する中、急性期と外来の両方で血行動態モニタリングツールの採用が拡大し続けると予想されます。

米国では、AIを搭載したモニタリングプラットフォームが、合併症の予測やリアルタイムの意思決定をサポートする能力で注目を集めています。脳血流インジケータ、音声およびジェスチャーコントロール、カスタマイズ可能なインターフェースなどの高度な機能は、高度急性期医療環境における臨床効率を高め、転帰を改善する、よりスマートで応答性の高いツールへのシフトを反映しています。例えば、BDは2025年4月、AIを搭載した血行動態モニタリングプラットフォームであるHemoSphere Altaを発売しました。これは、血流安定のための脳自動調節指数（CAI）と低血圧の予測ソフトウェアを備えています。このシステムは、カスタマイズ可能なタッチスクリーン、音声、ジェスチャーコントロールにより臨床医のワークフローを強化し、患者ケアの向上を目指しています。

血行動態モニタリング市場動向：

心臓関連合併症の負担増がモニタリング利用を促進

高血圧性心疾患とそれに関連する死亡例が後を絶たないことから、正確な心血管評価の必要性が高まっています。管理されていない血圧に関連する合併症に直面する人が増えるにつれ、病院やケアセンターは早期段階での介入をより重視しています。血行動態モニタリングの市場動向は、集中治療や手術後の回復期医療において、特に慢性心疾患患者の継続的な追跡が日常化していることを反映しています。このシフトは、心機能に関する正確でリアルタイムのフィードバックを提供する先進的なシステムの採用を促しています。臨床医がタイムリーなリスク検出と介入を優先する中、急性期医療と長期療養の両方で、情報に基づいた意思決定を支援し、転帰を改善するツールに対する需要は着実に高まっています。業界レポートによると、2021年の世界の高血圧性心疾患（HHD）の有病率は1,251万人、死亡率は133万人でした。2022年には、有病率は1,301万人に上昇し、死亡率は135万人となり、一貫した数値を示しています。

医療投資の増加がモニタリング技術の普及を促進

世界の医療支出は、疾病予防、患者の安全性、転帰重視のケアへの関心の高まりを反映して、経済生産のかなりの部分を占めるまでに成長しています。このような医療への広範なコミットメントは、測定可能な臨床的価値を提供できるテクノロジーにより多くのリソースが向けられ、調達戦略に影響を与えることで、血行動態モニタリング市場の見通しを形成しています。血行動態モニタリングシステムは、特にリアルタイムの心血管データが重要な意思決定に反映される高依存環境において、不可欠なツールと見なされるようになってきています。公共部門と民間部門の両方で資金が拡大するにつれて、病院は精密医療をサポートし、応答時間を改善し、手術や集中治療中の合併症を減少させるソリューションに投資する体制が整ってきています。データ情報に基づくケア・パスウェイとリソースの有効活用の推進により、高度なモニタリング機器、特に低侵襲でデジタル・ヘルス・エコシステムと互換性のある機器の統合が加速しています。このシフトは、複雑な症例をより正確に管理するために、診断の明確化と継続的な追跡への依存が高まっていることを示しています。例えば、世界経済フォーラムによると、2021年の世界の医療支出は9兆8,000億米ドルに達し、世界のGDPの10.3%に相当します。

統合された使いやすいモニタリング・プラットフォームへのシフト

血行動態モニタリングでは、コンパクトで多機能なシステムを求める動きが高まっています。臨床医は、特に時間とスペースが限られているクリティカルケアや手術室において、精度と使いやすさを兼ね備えたツールを求めています。このシフトには、複数のモニタリング技術を1つのデバイスに統合し、個別のセットアップの必要性を減らすプラットフォームへの嗜好の高まりも含まれます。タッチスクリーン・インターフェイス、モバイル設計、充電式電源などの機能は、プレッシャーの高い環境において柔軟性と継続的なサポートを提供し、人気を集めています。よりシンプルなインターフェースとセットアップ時間の短縮は、臨床チームの迅速な対応に役立ち、さまざまなソースからの統合データは意思決定を強化します。血行動態モニタリングの市場予測によると、急性期医療環境の進化に対応する、よりスマートで適応性の高いツールによって、ワークフローと患者の安全性の両方を向上させることに重点が置かれていることは明らかです。例えば2024年7月、Getinge社はCE認証を取得した先進的な血行動態モニタリングプラットフォームであるPulsiocareを発表しました。これはPiCCOとProAQTの技術を1つのモバイルモニターに統合したもので、充電式バッテリー、タッチスクリーン、直感的なユーザーインターフェースを備え、クリティカルケアや手術室環境向けに設計されています。

北米
- 米国
- カナダ
アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第10章 SWOT分析

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

第13章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Edwards Lifesciences Corporation
- Lidco Group PLC
- Deltex Medical Group PLC
- Pulsion Medical Systems SE
- GE Healthcare
- Osypka Medical GmbH
- Tensys Medical
- Teleflex Incorporated
- ICU Medical Inc.
- Argon Medical
- Schwarzer Cardiotek GmbH

図表

List of Figures

Figure 1: Global: Hemodynamic Monitoring Market: Major Drivers and Challenges
Figure 2: Global: Hemodynamic Monitoring Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Hemodynamic Monitoring Market: Breakup by Product (in %), 2024
Figure 4: Global: Hemodynamic Monitoring Market: Breakup by Monitoring (in %), 2024
Figure 5: Global: Hemodynamic Monitoring Market: Breakup by End-User (in %), 2024
Figure 6: Global: Hemodynamic Monitoring Market: Breakup by Region (in %), 2024
Figure 7: Global: Hemodynamic Monitoring Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 8: Global: Hemodynamic Monitoring (Disposables) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Hemodynamic Monitoring (Disposables) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Hemodynamic Monitoring (Monitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Hemodynamic Monitoring (Monitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Hemodynamic Monitoring (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Hemodynamic Monitoring (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Hemodynamic Monitoring (Invasive Monitoring) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Hemodynamic Monitoring (Invasive Monitoring) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Hemodynamic Monitoring (Minimally Invasive Monitoring) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Hemodynamic Monitoring (Minimally Invasive Monitoring) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Hemodynamic Monitoring (Noninvasive Monitoring) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Hemodynamic Monitoring (Noninvasive Monitoring) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Hemodynamic Monitoring (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Hemodynamic Monitoring (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Hemodynamic Monitoring (Clinics and Ambulatory Care Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Hemodynamic Monitoring (Clinics and Ambulatory Care Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Hemodynamic Monitoring (Home Care Settings) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Hemodynamic Monitoring (Home Care Settings) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Hemodynamic Monitoring (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Hemodynamic Monitoring (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: North America: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: North America: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: United States: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: United States: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Canada: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Canada: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Asia Pacific: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Asia Pacific: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: China: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: China: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Japan: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Japan: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: India: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: India: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: South Korea: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: South Korea: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Australia: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Australia: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Indonesia: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Indonesia: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Others: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Others: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Europe: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Europe: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Germany: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Germany: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: France: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: France: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: United Kingdom: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: United Kingdom: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Italy: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Italy: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Spain: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Spain: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Russia: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Russia: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Others: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Others: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Latin America: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Latin America: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Brazil: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Brazil: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Mexico: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Mexico: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Others: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Others: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Middle East and Africa: Hemodynamic Monitoring Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Middle East and Africa: Hemodynamic Monitoring Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Global: Hemodynamic Monitoring Industry: SWOT Analysis
Figure 77: Global: Hemodynamic Monitoring Industry: Value Chain Analysis
Figure 78: Global: Hemodynamic Monitoring Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Hemodynamic Monitoring Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Hemodynamic Monitoring Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Hemodynamic Monitoring Market Forecast: Breakup by Monitoring (in Million USD), 2025-2033
Table 4: Global: Hemodynamic Monitoring Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 5: Global: Hemodynamic Monitoring Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Hemodynamic Monitoring Market: Competitive Structure
Table 7: Global: Hemodynamic Monitoring Market: Key Players

Product Code: SR112025A2016

The global hemodynamic monitoring market size was valued at USD 1,196.88 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 1,731.81 Million by 2033, exhibiting a CAGR of 3.98% during 2025-2033. North America dominated the market, holding a significant market share of 35% in 2024. High healthcare spending, advanced hospital infrastructure, widespread adoption of monitoring technologies, skilled professionals, and strong regulatory support are some of the factors contributing to the hemodynamic monitoring market share.

The market is driven by several key factors. There's a growing demand for advanced monitoring systems in critical care due to the rising incidence of cardiovascular and respiratory diseases. An aging population and increased surgical procedures contribute to this demand. Hospitals and ICUs are prioritizing real-time, accurate monitoring to improve patient outcomes. Minimally invasive and non-invasive technologies are gaining popularity, as they reduce complications and recovery time. Technological improvements in sensors, data analytics, and wireless connectivity are making these systems more efficient and user-friendly. Additionally, government investments in healthcare infrastructure and an increased focus on early diagnosis and preventive care are supporting hemodynamic monitoring market growth. As healthcare systems push for better patient management, the adoption of hemodynamic monitoring tools in both acute and ambulatory settings is expected to continue expanding.

In the United States, AI-powered monitoring platforms are gaining attention for their ability to predict complications and support real-time decision-making. Advanced features like cerebral blood flow indicators, voice and gesture controls, and customizable interfaces reflect a shift toward smarter, more responsive tools that enhance clinical efficiency and improve outcomes in high-acuity care settings. For instance, in April 2025, BD launched HemoSphere Alta, an AI-powered hemodynamic monitoring platform. It features a cerebral autoregulation index (CAI) for blood flow stability and predictive software for hypotension. The system enhances clinician workflows with a customizable touchscreen, voice, and gesture controls, aiming to improve patient care.

Hemodynamic Monitoring Market Trends:

Growing Burden of Heart-Related Complications Driving Monitoring Use

Persistent cases of hypertensive heart conditions and related deaths have reinforced the medical need for precise cardiovascular assessment. As more individuals face complications linked to unmanaged blood pressure, hospitals and care centers are placing stronger emphasis on early-stage intervention. The hemodynamic monitoring market trend reflects that continuous patient tracking, especially for those with chronic cardiac issues, is becoming routine in intensive care and surgical recovery. This shift is encouraging the adoption of advanced systems that offer accurate, real-time feedback on heart function. With clinicians prioritizing timely risk detection and intervention, demand is steadily building for tools that can support informed decisions and improve outcomes across both acute and long-term care settings. As per an industry report, in 2021, global hypertensive heart disease (HHD) had a prevalence of 12.51 Million and a mortality rate of 1.33 Million. By 2022, the prevalence rose to 13.01 Million, with a mortality rate of 1.35 Million, showing consistent figures.

Rising Healthcare Investment Fuels Monitoring Technology Uptake

Global health spending has grown to occupy a substantial portion of economic output, reflecting increased attention to disease prevention, patient safety, and outcome-driven care. This broader commitment to healthcare is shaping the hemodynamic monitoring market outlook by influencing procurement strategies, with more resources being directed toward technologies that can deliver measurable clinical value. Hemodynamic monitoring systems are increasingly viewed as essential tools, especially in high-dependency environments where real-time cardiovascular data informs critical decisions. As funding expands across both public and private sectors, hospitals are better equipped to invest in solutions that support precision medicine, improve response times, and reduce complications during surgical or intensive care. The push for data-informed care pathways and better resource utilization is accelerating the integration of advanced monitoring devices, especially those that are minimally invasive and compatible with digital health ecosystems. This shift points to growing reliance on diagnostic clarity and continuous tracking to manage complex cases with greater accuracy. For example, in 2021, global health spending reached an astounding USD 9.8 Trillion, representing 10.3% of the world's GDP, according to the World Economic Forum.

Shift toward Integrated and User-Friendly Monitoring Platforms

There is a growing movement toward compact, multifunctional systems in hemodynamic monitoring. Clinicians are seeking tools that merge accuracy with ease of use, especially in critical care and operating rooms where time and space are limited. The shift includes increased preference for platforms that combine multiple monitoring technologies in one device, reducing the need for separate setups. Features like touchscreen interfaces, mobile design, and rechargeable power are gaining traction, offering flexibility and continuous support in high-pressure settings. Simpler interfaces and faster setup times help clinical teams respond quickly, while integrated data from various sources enhances decision-making. As per the hemodynamic monitoring market forecast, the focus is clearly on improving both workflow and patient safety through smarter, more adaptable tools that meet the evolving demands of acute care environments. For instance, in July 2024, Getinge launched Pulsiocare, an advanced hemodynamic monitoring platform with a CE certificate. It combines PiCCO and ProAQT technologies into a single mobile monitor with a rechargeable battery, touchscreen, and an intuitive user interface, designed for critical care and operating room environments.

Hemodynamic Monitoring Industry Segmentation:

Analysis by Product:

Disposables
Monitors
Others

Monitors stood as the largest product in 2024, holding around 63% of the market. These devices provide continuous, real-time tracking of cardiovascular parameters such as blood pressure, cardiac output, and oxygen levels, which are essential for managing critically ill patients. Hospitals and emergency care units rely on these monitors to make fast, informed decisions during surgeries, trauma, or intensive care. The demand is increasing due to rising cardiovascular disease cases, expanding ICU admissions, and the shift toward minimally invasive procedures that still require detailed monitoring. Technological improvements like wireless connectivity and integration with electronic health records also make these systems more attractive, supporting broader adoption across healthcare facilities. As a result, monitors are a key revenue-driving segment in this space.

Analysis by Monitoring:

Invasive Monitoring
Minimally Invasive Monitoring
Noninvasive Monitoring

Invasive monitoring led the market in 2024 due to its accuracy and reliability in critical care. These systems involve the insertion of catheters or sensors directly into the body, allowing precise measurement of parameters like arterial pressure, central venous pressure, and pulmonary artery pressure. Clinicians prefer invasive methods for high-risk surgeries, trauma cases, and severe cardiac conditions, where non-invasive tools may not provide sufficient data. The growing number of complex surgical procedures, especially in cardiac and transplant units, is boosting demand. Advancements in catheter design and integration with digital monitoring platforms have also improved safety and usability, leading to higher adoption in operating rooms and ICUs across both developed and emerging healthcare systems.

Analysis by End-User:

Hospitals
Clinics and Ambulatory Care Centers
Home Care Settings
Others

Hospitals led the market with around 43.2% of market share in 2024, owing to the high volume of critical care, surgical, and emergency procedures performed in these settings. Hospitals have the infrastructure and trained personnel to support invasive and non-invasive monitoring technologies, making them the primary users of advanced hemodynamic systems. Rising admissions for cardiovascular diseases, sepsis, and multi-organ failure cases drive the need for continuous and accurate monitoring. Government investments in hospital infrastructure, especially in emerging economies, further support adoption. Integration of monitoring systems with hospital information systems improves workflow and patient management, encouraging upgrades. As patient loads grow and clinical demands increase, hospitals continue to be the leading buyers of hemodynamic monitoring equipment.

Regional Analysis:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

In 2024, North America accounted for the largest market share of 35% due to a combination of advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative medical technologies. The region has a large base of critical care and surgical procedures, which increases the need for precise monitoring tools. The presence of major medical device manufacturers, strong distribution networks, and continuous investment in research and development contribute to market leadership. Additionally, the rising prevalence of cardiovascular and respiratory diseases, especially among the aging population, drives demand for both invasive and non-invasive hemodynamic monitoring systems. Favorable reimbursement policies, widespread use of electronic health records, and skilled healthcare professionals further support adoption. The U.S. accounts for the largest share within the region, reflecting its robust hospital networks and ongoing emphasis on improving patient outcomes through advanced monitoring solutions.

Key Regional Takeaways:

United States Hemodynamic Monitoring Market Analysis

In 2024, the United States accounted for 88.1% of the market share in North America. The US hemodynamic monitoring market is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs) and other chronic conditions. The American Heart Association (AHA) reported that in 2022, cardiovascular disease (CVD) caused 941,652 deaths in the U.S. Between 2017 and 2020, 127.9 Million adults had CVD. The total direct and indirect costs of CVD from 2020 to 2021 were USD 417.9 Billion. In line with this, the growing adoption of minimally invasive technologies, enabling safer and more efficient patient care, is propelling the market growth. Additionally, the rising demand for early detection and personalized treatment strategies is fostering market expansion. The ongoing shift toward value-based healthcare models, which prioritize improved patient outcomes, is further encouraging the use of hemodynamic monitoring systems. Furthermore, continual technological advancements in artificial intelligence and machine learning are enhancing data analytics and predictive capabilities, augmenting product sales. Similarly, the aging population's growing healthcare needs promoting demand for intensive care solutions, is strengthening market demand. Moreover, the rising healthcare spending by both public and private sectors supporting the adoption of cutting-edge monitoring systems, is providing an impetus to the market.

Europe Hemodynamic Monitoring Market Analysis

The European hemodynamic monitoring market is experiencing growth due to the increasing prevalence of cardiovascular diseases (CVDs) and hypertension. In accordance with this, the region's focus on improving patient outcomes through precision medicine is encouraging the adoption of hemodynamic monitoring systems. Similarly, the growing elderly population requiring intensive care is further strengthening market demand. The rise in non-invasive sensor technologies, which offer enhanced accuracy and patient comfort, is fueling market expansion. Additionally, Europe's strong healthcare infrastructure and investments in advanced medical technologies are supporting the widespread use of hemodynamic monitoring devices. As such, in December 2024, the European Investment Bank (EIB) provided EUR 35 Million in financing to GVM Group, supported by InvestEU. The funds will support medical technology development, clinical research, and digital infrastructure improvements across GVM's healthcare facilities, with projects to be completed by 2027. Furthermore, favorable reimbursement policies in countries like Germany and the UK are promoting market development. The increasing emphasis on early detection and prevention of complications is also facilitating market growth. Besides this, the growing number of surgical procedures requiring real-time monitoring is creating lucrative opportunities in the market.

Asia Pacific Hemodynamic Monitoring Market Analysis

The market in Asia Pacific is predominantly propelled by the rapid expansion of healthcare infrastructure, which is improving access to advanced medical technologies across the region. In addition to this, the rising prevalence of lifestyle diseases such as diabetes and hypertension is augmenting demand in the market. According to the 2023 Indian Council of Medical Research - India Diabetes (ICMR INDIAB) study, the prevalence of diabetes in India stands at 10.1 crores. Similarly, the growing adoption of smart healthcare technologies, including wearable devices, is contributing to market growth. Furthermore, increasing healthcare expenditure by both governments and private sectors is facilitating the higher implementation of advanced hemodynamic monitoring systems. Likewise, the rising number of surgical procedures and critical care cases in countries like China and India is further propelling the market development. Moreover, the region's heightened focus on improving healthcare quality and patient outcomes through early intervention is impacting the market trends.

Latin America Hemodynamic Monitoring Market Analysis

In Latin America, the hemodynamic monitoring market is progressing, driven by the increasing healthcare investment from both public and private sectors. Furthermore, the rising awareness about early diagnosis and proactive patient management is fueling market demand. Additionally, the growing prevalence of cardiovascular diseases across the region is contributing to market growth. Apart from this, the expansion of healthcare facilities, especially in emerging markets like Brazil and Mexico, is enhancing access to advanced monitoring technologies, thus expanding the market's scope. Accordingly, in September 2024, Rede D'Or, Brazil's leading hospital group, plans to invest BRL 7.5 Billion by 2028, adding 5,400 beds, increasing capacity by 46%. The expansion will augment efficiency, with the company aiming for 200-bed hospitals and investing BRL 1.5 Million per bed.

Middle East and Africa Hemodynamic Monitoring Market Analysis

The market in the Middle East and Africa is significantly influenced by increasing government investments in healthcare infrastructure. In parallel, the rising prevalence of chronic diseases like hypertension and diabetes is driving market growth. Industry analysis reported that in Abu Dhabi, the age-adjusted hypertension prevalence increased from 24.5% at baseline to 35.2% in 2023. Also, the proportion of hypertensive patients with controlled blood pressure rose from 61.8% at baseline to 74.3% in 2023. Additionally, the region's growing focus on medical tourism, particularly in countries such as the UAE and Saudi Arabia, is stimulating market appeal. Besides this, the heightened adoption of digital health solutions and telemedicine is improving patient monitoring capabilities, thereby strengthening the market presence.

Competitive Landscape:

The market is seeing increased activity across product launches, partnerships, agreements, funding rounds, and R&D efforts. Companies are prioritizing real-time data integration, AI-based analytics, and minimally invasive technologies. Collaborations between device manufacturers and software firms are helping integrate advanced monitoring with existing clinical systems. Strategic agreements are also being used to expand distribution channels and enhance regional presence. Research is focused on improving predictive monitoring and patient outcomes in critical care settings. Government support is driving innovation, especially in public health systems adopting remote or advanced ICU technologies. Among these, product launches and collaborative agreements have become common practices, often used to introduce next-generation platforms or strengthen market positioning without building from scratch.

The report provides a comprehensive analysis of the competitive landscape in the hemodynamic monitoring market with detailed profiles of all major companies, including:

Edwards Lifesciences Corporation
Lidco Group PLC
Deltex Medical Group PLC
Pulsion Medical Systems SE
GE Healthcare
Osypka Medical GmbH
Tensys Medical
Teleflex Incorporated
ICU Medical Inc.
Argon Medical
Schwarzer Cardiotek GmbH

Key Questions Answered in This Report

1.How big is the hemodynamic monitoring market?
2.What is the future outlook of hemodynamic monitoring market?
3.What are the key factors driving the hemodynamic monitoring market?
4.Which region accounts for the largest hemodynamic monitoring market share?
5.Which are the leading companies in the global hemodynamic monitoring market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Hemodynamic Monitoring Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Disposables
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Monitors
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Monitoring

7.1 Invasive Monitoring
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Minimally Invasive Monitoring
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Noninvasive Monitoring
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by End-User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Clinics and Ambulatory Care Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Home Care Settings
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Edwards Lifesciences Corporation
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Lidco Group PLC
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
- 13.3.3 Deltex Medical Group PLC
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
- 13.3.4 Pulsion Medical Systems SE
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
- 13.3.5 GE Healthcare
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
- 13.3.6 Osypka Medical GmbH
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
- 13.3.7 Tensys Medical
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
- 13.3.8 Teleflex Incorporated
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
- 13.3.9 ICU Medical Inc.
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
- 13.3.10 Argon Medical
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
- 13.3.11 Schwarzer Cardiotek GmbH
  - 13.3.11.1 Company Overview
  - 13.3.11.2 Product Portfolio

血行動態モニタリング市場：市場規模・シェア・動向・予測、製品別、モニタリング手法別、エンドユーザー別、地域別（2025～2033年）

Hemodynamic Monitoring Market Size, Share, Trends and Forecast by Product, Monitoring, End-User, and Region, 2025-2033

血行動態モニタリング市場動向：

目次

第1章 序文

第2章 分析範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の血行動態モニタリング市場

第6章 市場区分：製品別

第7章 市場区分：モニタリング手法別

第8章 市場区分：エンドユーザー別

第9章 市場区分：地域別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 競合情勢